PT Medela Potentia Achieves Rp8.2 Trillion in Sales for First Half of 2026
PT Medela Potentia Tbk (MDLA) recorded sales of Rp8.2 trillion in the first semester of 2026, representing a 10.1 per cent growth compared to the same period in the previous year.
This growth was accompanied by a 12.6 per cent increase in net profit to Rp226 billion, gross profit reaching Rp762 billion (up 6.8 per cent), and EBITDA growing by 11.2 per cent to Rp325 billion.
Investor Relations for PT Medela Potentia Tbk, Harris Lesmana, stated in Jakarta on Wednesday that the performance growth in the first half of 2026 was supported by several complementary drivers, ranging from distribution volume expansion and the addition of new principals to the strengthening of owned products and the optimisation of digital channels.
From an operational perspective, the company continues to improve productivity and work process efficiency. “We see that there is still room to increase capacity, productivity, and efficiency alongside business growth,” he said.
In the distribution line, the subsidiary PT Anugrah Argon Medica (AAM) continues to strengthen its business portfolio by adding five new principals, consisting of one ethical principal, three consumer health principals, and one medical device principal.
In the medical device line for owned products, the Stardec product, marketed by the subsidiary PT Djembatan Dua, recorded a sales growth of 34 per cent. Stardec products were also exported to Cambodia and Timor-Leste in 2025, with plans for further exports in 2026.
Meanwhile, the President Director of PT Medela Potentia Tbk, Juliwaty, added that the company’s growth in the first half of 2026 reflects its strengthening position within the Indonesian healthcare ecosystem.
The company, she added, continues to strengthen its infrastructure capacity to capture growth opportunities in the demand for healthcare product distribution.
Construction of the AAM Medan warehouse has reached 95 per cent and is targeted to begin operations in the fourth quarter of 2026, which will enhance distribution capabilities in the Sumatra region.
The company plans to construct a second National Distribution Centre (NDC 2) on a 2.7-hectare site in the Jababeka 2 Industrial Estate in 2027, which will focus on cold storage requirements.
The company’s digital business line, GPOS B2B, recorded a sales growth of 20 per cent with coverage growth reaching 15 per cent. GPOS B2B works with 18 principals and covers 40 product brands. The implementation of AI Forecast has helped the company reduce out-of-stock levels to below 2 per cent.